Theratechnologies Financial Statements From 2010 to 2024

Theratechnologies Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 65.2 M 89.4 M 67.7 M Slightly volatile Short and Long Term Debt Total 38.1 M 67.8 M 37 M Slightly volatile Total Current Liabilities 57.1 M 54.4 M 33 M Slightly volatile Property Plant And Equipment Net 1.3 M 1.8 M 1.3 M Slightly volatile Accounts Payable 6.4 M 8 M 7.5 M Slightly volatile Cash 41.2 M 39.2 M 17.6 M Slightly volatile Non Current Assets Total 29.9 M 16.6 M 21.6 M Slightly volatile Other Assets 2.2 M 2.1 M 727.6 K Slightly volatile Cash And Short Term Investments 48.8 M 46.4 M 24.5 M Slightly volatile Net Receivables 15.5 M 14.7 M 7.9 M Slightly volatile Common Stock Shares Outstanding 55.9 M 30.3 M 62.1 M Pretty Stable Liabilities And Stockholders Equity 65.2 M 89.4 M 67.7 M Slightly volatile Non Current Liabilities Total 62 M 59 M 28.9 M Slightly volatile Inventory 7.8 M 7 M 12.5 M Pretty Stable Other Current Assets 2.4 M 4.1 M 3.7 M Slightly volatile Other Stockholder Equity 19.8 M 20.9 M 14.1 M Slightly volatile Total Liabilities 119.1 M 113.4 M 61.9 M Slightly volatile Property Plant And Equipment Gross 3 M 2.9 M 1.7 M Slightly volatile Total Current Assets 76.4 M 72.8 M 48.8 M Slightly volatile Short Term Debt 8.8 M 8.9 M 8.9 M Slightly volatile Intangible Assets 12.3 M 14.4 M 14.8 M Slightly volatile Other Current Liabilities 39.3 M 37.4 M 18.9 M Slightly volatile Short Term Investments 9.9 M 5.7 M 8.3 M Slightly volatile Current Deferred Revenue 32.5 K 34.2 K 1.2 M Slightly volatile Other Liabilities 90.6 K 95.4 K 3.8 M Slightly volatile Deferred Long Term Liabilities 1.7 M 1.6 M 1.3 M Pretty Stable Short and Long Term Debt 8 M 8.4 M 25 M Slightly volatile Common Stock 306.6 M 418.5 M 289.9 M Slightly volatile Property Plant Equipment 3.7 M 3.6 M 1.5 M Slightly volatile Common Stock Total Equity 278.7 M 330.4 M 268.4 M Slightly volatile Long Term Debt Total 1.6 M 1.7 M 18.6 M Very volatile Capital Surpluse 12.7 M 21.6 M 11.4 M Slightly volatile Non Current Liabilities Other 35.1 K 36.9 K 3.5 M Slightly volatile Net Invested Capital 45.8 M 33.4 M 45.4 M Slightly volatile Cash And Equivalents 10 M 8.3 M 13.4 M Slightly volatile Capital Stock 342 M 418.5 M 292.9 M Slightly volatile Capital Lease Obligations 1.7 M 894.6 K 2.5 M Slightly volatile
Theratechnologies Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 3.1 M 3.8 M 3.9 M Slightly volatile Selling General Administrative 18.9 M 18 M 9.1 M Slightly volatile Total Revenue 98.7 M 94 M 47.2 M Slightly volatile Gross Profit 75 M 71.4 M 33.3 M Slightly volatile Other Operating Expenses 111.6 M 106.2 M 57.6 M Slightly volatile Research Development 36.7 M 34.9 M 16.2 M Slightly volatile Cost Of Revenue 23.7 M 22.6 M 13.9 M Slightly volatile Total Operating Expenses 87.9 M 83.7 M 43.7 M Slightly volatile Selling And Marketing Expenses 16.1 M 30.8 M 17.4 M Slightly volatile Interest Income 840.1 K 884.4 K 2.4 M Very volatile Reconciled Depreciation 7.3 M 3.8 M 4.4 M Slightly volatile
Theratechnologies Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 28.8 M 27.4 M 13.5 M Slightly volatile Depreciation 3.1 M 3.8 M 3.9 M Slightly volatile Capital Expenditures 2.2 M 2.1 M 879 K Slightly volatile End Period Cash Flow 41.2 M 39.2 M 17.5 M Slightly volatile Stock Based Compensation 2.4 M 2.3 M 1.2 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 0.56 0.59 59.4486 Slightly volatile Days Sales Outstanding 62.42 65.7 273 Slightly volatile Average Payables 3.5 M 2.3 M 2.1 M Slightly volatile Stock Based Compensation To Revenue 0.0273 0.0312 0.0227 Slightly volatile Capex To Depreciation 0.88 0.63 0.5195 Slightly volatile EV To Sales 0.89 0.94 58.5382 Slightly volatile Inventory Turnover 3.06 2.91 1.1875 Slightly volatile Days Of Inventory On Hand 107 101 893 Slightly volatile Payables Turnover 2.65 2.53 2.1924 Very volatile Sales General And Administrative To Revenue 0.34 0.22 0.2843 Slightly volatile Average Inventory 15.1 M 14.4 M 12 M Slightly volatile Research And Ddevelopement To Revenue 0.41 0.43 0.8536 Slightly volatile Capex To Revenue 0.0243 0.0256 0.059 Slightly volatile Cash Per Share 1.85 1.76 0.5658 Slightly volatile Intangibles To Total Assets 0.14 0.1607 0.206 Very volatile Current Ratio 1.46 1.54 1.9986 Slightly volatile Receivables Turnover 5.69 5.75 6.1796 Very volatile Graham Number 2.43 4.63 1.544 Slightly volatile Capex Per Share 0.0834 0.0794 0.0243 Slightly volatile Average Receivables 4 M 3.8 M 3.4 M Slightly volatile Revenue Per Share 2.93 2.79 0.9584 Slightly volatile Interest Debt Per Share 2.46 2.34 0.7448 Slightly volatile Debt To Assets 0.7 0.67 0.4357 Slightly volatile Operating Cycle 161 153 1.2 K Slightly volatile Ebt Per Ebit 2.09 1.99 1.2917 Slightly volatile Long Term Debt To Capitalization 1.61 1.53 0.8729 Slightly volatile Total Debt To Capitalization 1.48 1.41 0.7598 Slightly volatile Quick Ratio 1.32 1.39 1.2847 Pretty Stable Net Income Per E B T 1.09 1.17 0.9567 Slightly volatile Cash Ratio 1.19 0.83 0.6565 Very volatile Days Of Inventory Outstanding 107 101 893 Slightly volatile Days Of Sales Outstanding 62.42 65.7 273 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.86 1.19 1.0447 Pretty Stable Fixed Asset Turnover 35.38 37.24 169 Pretty Stable Debt Ratio 0.7 0.67 0.4357 Slightly volatile Price Sales Ratio 0.56 0.59 59.4486 Slightly volatile Asset Turnover 0.99 0.95 0.5865 Slightly volatile Gross Profit Margin 0.96 0.87 0.7088 Slightly volatile
Theratechnologies Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 35.7 M 37.6 M 575 M Very volatile Enterprise Value 56.9 M 59.9 M 588.4 M Pretty Stable

Theratechnologies Fundamental Market Drivers

About Theratechnologies Financial Statements

Pair Trading with Theratechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:

How To Invest In Theratechnologies Details

Is Theratechnologies Stock a good investment? Details

What is Theratechnologies' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Intrinsic Valuation Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details

Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.